Xenon Pharmaceuticals IncNASDAQ:XENE
- LAST PRICE40.5400
- TODAY'S CHANGE (%)-1.9500 (-4.5893%)
- Bid / Lots35.0000/ 1
- Ask / Lots64.7200/ 2
- Open / Previous Close40.7600 / 42.4900
- Day Range
- 52 Week Range
- Volume527,882
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | XENE |
|---|---|---|
| 09:32 ET | 6519 | 39.085 |
| 09:34 ET | 100 | 39.5 |
| 09:36 ET | 3400 | 39.64 |
| 09:38 ET | 4800 | 39.785 |
| 09:39 ET | 11058 | 41.18 |
| 09:41 ET | 4982 | 41.54 |
| 09:43 ET | 7700 | 41.03 |
| 09:45 ET | 300 | 41.25 |
| 09:48 ET | 1367 | 41.93 |
| 09:50 ET | 400 | 41.8 |
| 09:52 ET | 1713 | 42.48 |
| 09:54 ET | 5045 | 42.5 |
| 09:56 ET | 100 | 42.355 |
| 09:57 ET | 300 | 42.33 |
| 09:59 ET | 1500 | 42.03 |
| 10:01 ET | 215 | 42.03 |
| 10:03 ET | 6572 | 42.465 |
| 10:06 ET | 200 | 42.47 |
| 10:08 ET | 1300 | 42.475 |
| 10:10 ET | 400 | 42.475 |
| 10:12 ET | 1800 | 42.275 |
| 10:14 ET | 1200 | 42.45 |
| 10:15 ET | 800 | 42.365 |
| 10:17 ET | 100 | 42.175 |
| 10:19 ET | 2001 | 41.56 |
| 10:21 ET | 100 | 41.275 |
| 10:24 ET | 9114 | 41.3626 |
| 10:26 ET | 4059 | 41.535 |
| 10:28 ET | 400 | 41.495 |
| 10:30 ET | 1888 | 41.12 |
| 10:32 ET | 100 | 41.19 |
| 10:33 ET | 400 | 41.15 |
| 10:35 ET | 823 | 41.0528 |
| 10:37 ET | 2023 | 41.35 |
| 10:39 ET | 200 | 41.23 |
| 10:42 ET | 200 | 41.17 |
| 10:44 ET | 1103 | 41.05 |
| 10:46 ET | 4959 | 41.1 |
| 10:48 ET | 200 | 41.05 |
| 10:50 ET | 600 | 41.095 |
| 10:51 ET | 2557 | 41.15 |
| 10:53 ET | 2627 | 41 |
| 10:55 ET | 400 | 41 |
| 10:57 ET | 400 | 41.03 |
| 11:00 ET | 200 | 41 |
| 11:02 ET | 100 | 40.96 |
| 11:04 ET | 1036 | 41.49 |
| 11:06 ET | 1052 | 41.355 |
| 11:09 ET | 200 | 41.1 |
| 11:11 ET | 400 | 41.195 |
| 11:13 ET | 100 | 41.2 |
| 11:15 ET | 7779 | 41.1 |
| 11:18 ET | 1200 | 41.18 |
| 11:20 ET | 1900 | 41.11 |
| 11:24 ET | 800 | 41.165 |
| 11:26 ET | 500 | 41.16 |
| 11:27 ET | 1136 | 41.1 |
| 11:29 ET | 300 | 41.11 |
| 11:31 ET | 4761 | 40.93 |
| 11:33 ET | 400 | 40.93 |
| 11:36 ET | 600 | 40.975 |
| 11:40 ET | 1300 | 40.925 |
| 11:42 ET | 612 | 40.91 |
| 11:44 ET | 1400 | 40.875 |
| 11:45 ET | 500 | 40.94 |
| 11:47 ET | 1100 | 40.93 |
| 11:51 ET | 400 | 40.93 |
| 11:54 ET | 2708 | 40.83 |
| 11:56 ET | 1110 | 40.79 |
| 11:58 ET | 300 | 40.79 |
| 12:00 ET | 200 | 40.82 |
| 12:03 ET | 300 | 40.76 |
| 12:05 ET | 600 | 40.42 |
| 12:07 ET | 400 | 40.435 |
| 12:09 ET | 100 | 40.43 |
| 12:12 ET | 400 | 40.315 |
| 12:14 ET | 200 | 40.155 |
| 12:16 ET | 3870 | 40.44 |
| 12:20 ET | 1700 | 40.07 |
| 12:21 ET | 1226 | 40.05 |
| 12:23 ET | 1100 | 40.04 |
| 12:25 ET | 32864 | 39.965 |
| 12:27 ET | 2400 | 40.08 |
| 12:30 ET | 500 | 40.085 |
| 12:32 ET | 1000 | 39.995 |
| 12:34 ET | 3764 | 39.7 |
| 12:36 ET | 300 | 39.84 |
| 12:38 ET | 300 | 39.88 |
| 12:39 ET | 200 | 39.885 |
| 12:41 ET | 200 | 39.885 |
| 12:43 ET | 2716 | 40.195 |
| 12:45 ET | 100 | 40.29 |
| 12:48 ET | 100 | 40.22 |
| 12:50 ET | 2355 | 40.185 |
| 12:52 ET | 700 | 40.175 |
| 12:54 ET | 100 | 40.23 |
| 12:59 ET | 700 | 40.32 |
| 01:01 ET | 2300 | 40.66 |
| 01:03 ET | 900 | 40.72 |
| 01:06 ET | 1900 | 40.71 |
| 01:08 ET | 200 | 40.725 |
| 01:10 ET | 100 | 40.68 |
| 01:12 ET | 11724 | 40.53 |
| 01:14 ET | 400 | 40.515 |
| 01:15 ET | 1600 | 40.43 |
| 01:17 ET | 1400 | 40.305 |
| 01:19 ET | 100 | 40.36 |
| 01:21 ET | 400 | 40.275 |
| 01:26 ET | 1200 | 40.555 |
| 01:28 ET | 290 | 40.58 |
| 01:30 ET | 3459 | 40.47 |
| 01:32 ET | 300 | 40.45 |
| 01:33 ET | 400 | 40.37 |
| 01:42 ET | 700 | 40.305 |
| 01:44 ET | 2036 | 40.41 |
| 01:48 ET | 1555 | 40.51 |
| 01:50 ET | 1200 | 40.455 |
| 01:51 ET | 372 | 40.54 |
| 01:53 ET | 700 | 40.445 |
| 01:55 ET | 133 | 40.44 |
| 01:57 ET | 300 | 40.54 |
| 02:00 ET | 600 | 40.545 |
| 02:02 ET | 900 | 40.4 |
| 02:04 ET | 100 | 40.44 |
| 02:06 ET | 200 | 40.45 |
| 02:08 ET | 200 | 40.46 |
| 02:09 ET | 100 | 40.53 |
| 02:11 ET | 300 | 40.465 |
| 02:15 ET | 2995 | 40.45 |
| 02:18 ET | 400 | 40.48 |
| 02:20 ET | 600 | 40.28 |
| 02:22 ET | 1620 | 40.345 |
| 02:24 ET | 100 | 40.28 |
| 02:26 ET | 200 | 40.36 |
| 02:27 ET | 700 | 40.375 |
| 02:29 ET | 699 | 40.375 |
| 02:33 ET | 600 | 40.345 |
| 02:36 ET | 2872 | 40.25 |
| 02:38 ET | 3374 | 40.33 |
| 02:42 ET | 100 | 40.345 |
| 02:44 ET | 200 | 40.34 |
| 02:45 ET | 1300 | 40.305 |
| 02:47 ET | 1300 | 40.305 |
| 02:49 ET | 100 | 40.305 |
| 02:51 ET | 100 | 40.305 |
| 02:54 ET | 3398 | 40.36 |
| 02:56 ET | 200 | 40.36 |
| 02:58 ET | 1100 | 40.3 |
| 03:00 ET | 300 | 40.31 |
| 03:02 ET | 200 | 40.29 |
| 03:03 ET | 200 | 40.31 |
| 03:05 ET | 100 | 40.31 |
| 03:07 ET | 604 | 40.3 |
| 03:09 ET | 11070 | 40.61 |
| 03:12 ET | 3436 | 40.565 |
| 03:14 ET | 1600 | 40.545 |
| 03:16 ET | 2635 | 40.485 |
| 03:18 ET | 1600 | 40.465 |
| 03:20 ET | 300 | 40.48 |
| 03:21 ET | 1100 | 40.265 |
| 03:23 ET | 600 | 40.285 |
| 03:27 ET | 100 | 40.31 |
| 03:30 ET | 1197 | 40.33 |
| 03:32 ET | 9635 | 40.465 |
| 03:34 ET | 200 | 40.48 |
| 03:36 ET | 2726 | 40.61 |
| 03:38 ET | 500 | 40.56 |
| 03:39 ET | 100 | 40.55 |
| 03:41 ET | 2000 | 40.58 |
| 03:43 ET | 800 | 40.54 |
| 03:45 ET | 2055 | 40.58 |
| 03:48 ET | 1300 | 40.54 |
| 03:50 ET | 4142 | 40.55 |
| 03:52 ET | 7754 | 40.51 |
| 03:54 ET | 5432 | 40.61 |
| 03:56 ET | 4354 | 40.5 |
| 03:57 ET | 6302 | 40.52 |
| 03:59 ET | 11746 | 40.54 |
Yesterday
DJ Xenon Pharmaceuticals Is Maintained at Buy by Needham, from 9 hours ago by Dow Jones
9 hours ago by Dow JonesDJ Xenon Pharmaceuticals Is Maintained at Buy by Citigroup, from 9 hours ago by Dow Jones
9 hours ago by Dow JonesDJ Xenon Pharmaceuticals Is Maintained at Outperform by Wedbush, from 17 hours ago by Dow Jones
17 hours ago by Dow Jones
May 9, 2024
Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update, from 4:01PM ET on Thursday May 09, 2024 by Dow Jones
4:01PM ET on Thursday May 09, 2024 by Dow Jones*DJ Xenon Pharmaceuticals 1Q Loss/Shr 62c >XENE, from 4:01PM ET on Thursday May 09, 2024 by Dow Jones
4:01PM ET on Thursday May 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Xenon Pharmaceuticals Inc | 3.2B | -14.9x | --- |
SpringWorks Therapeutics Inc | 3.2B | -7.9x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Summit Therapeutics Inc | 3.4B | -3.0x | --- |
Apogee Therapeutics Inc | 3.0B | -30.6x | --- |
IDEAYA Biosciences Inc | 3.1B | -20.6x | --- |
Company Information
Xenon Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company focused on developing therapeutics to improve the lives of patients with neurological disorders, with a focus on epilepsy. The Company’s product pipeline includes XEN1101 (Focal Onset Seizures), XEN1101 (Primary Generalized Tonic-Clonic Seizures), XEN1101 (Major Depressive Disorder) and NBI-921352 (NEUROCRINE). It is developing XEN1101, a differentiated Kv7 potassium channel opener, for the treatment of epilepsy, MDD and potentially other neurological disorders. Its XEN1101 Phase III epilepsy program includes two identical Phase III clinical trials, called X-TOLE2 and X-TOLE3, that are designed closely after the Phase IIb X-TOLE clinical trial. Its Phase III X-ACKT clinical trial is intended to support potential regulatory submissions in an additional epilepsy indication of primary generalized tonic-clonic seizures (PGTCS).
Contact Information
- Headquarters
- 3650 Gilmore WayVANCOUVER, BC, Canada V5G 4W8
- Phone
- 604-484-3300
- Fax
- 604-484-3450
Executives
- Chairman of the Board
- Simon Pimstone
- President, Chief Executive Officer, Director
- Ian Mortimer
- Chief Financial Officer
- Sherry Aulin
- Executive Vice President - Drug Discovery
- James Empfield
- Executive Vice President - Strategy and Innovation
- Robin Sherrington
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.1B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 75.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.25 |
EPS | $-2.71 |
Book Value | $12.31 |
P/E Ratio | -14.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
